ConvaTec Group PLC (LSE:CTEC) - Share price


Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX216.80

Day Change
2.60|1.21%

As of 26/05/2022
18:24:35 BST | GBX
Minimum 15 Minutes Delay.

Last Close214.20p
Day Range213.80 - 220.00
Mkt Cap4.37Bil
52-Wk Range165.30 - 265.00
Yield %2.05
ISINGB00BD3VFW73
Volume5,603,486
P/E46.30
P/S2.16
P/CF14.36

Share Price

Total Returns 26/05/2022

 Chg (%)  
More ...
ConvaTec Group PLC0.56 
FTSE 100 TR GBP2.81
 
Financials
201920202021
More ...
Income Statement
Turnover1,827.201,894.302,038.30
Operating Profit202.40211.00203.60
Net Profit9.80112.50117.60
Reported EPS0.010.060.06
Balance Sheet
Current Assets968.301,178.501,110.80
Non Current Assets2,641.502,588.002,563.20
Total Assets3,609.803,766.503,674.00
Current Liabilities397.30513.20569.20
Total Liabilities2,048.802,095.801,979.20
Total Equity1,561.001,670.701,694.80
Cash Flow
Operating Cash Flow438.80454.00365.10
Net Change in Cash76.50181.10-100.50

Regulatory News

DateAuthor Headline
08/11/2018Alex Morozov, CFA Vodafone Added to Value Stocks List
UK accountancy tech firm Sage was booted off the Morningstar Europe Core Pick List of the most attractively valued stocks, but Vodafone was added
03/08/2018Alex Morozov, CFA 7 UK Stocks Make the European Value Picks List
The Morningstar Europe Core Pick List features the most attractively valued stocks that possess sustainable competitive advantages
25/07/2018David Brenchley Disruptor Stocks Grabbing Profit in Europe
Europe's traditional stocks look like value traps, according to Carmignac. Disruptive firms ASOS and Delivery Hero offer better returns, despite their expense
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
14/10/2021DMr. Rick D. Anderson226.08433979.00
14/10/2021DMr. Frank Schulkes202.402551.00
30/07/2021PurchaseProfessor Constantin Coussios235.628,44019,887.00

Company Profile

Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy are the largest divisions, accounting for 33% and 30% of total revenue, respectively. Continence care contributes 21% of revenue and infusion sets 15%.

Sector

Medical Instruments & Supplies

Index

FTSE 250 , FTSE 350 , FTSE All Share

Next Event 29/07/2022

Half-Yearly Results
Ratios
Comp
More ...
PER (E)45.55
Div Yld (E)2.07
PEG (E)3.05
ROCE6.04
Op Mrgn0.10
EPS Grwth0.44
Dividends
PreviousLatest
More ...
Record Date03/09/2101/04/22
Ex-Div02/09/2131/03/22
Paid14/10/2119/05/22
Amnt1.233.16
Directors
More ...
Non-Executive DirectorMs. Heather L. Mason
Non-Executive DirectorProfessor Sten Scheibye, PhD
Non-Executive Director, ChairmanDr. John David Gibson McAdam CBE
Non-Executive DirectorMr. Brian Michael May
Non-Executive Director, Senior Independent DirectorMs. Margaret Ewing
Executive Director, Chief Executive OfficerMr. Karim Bitar
Non-Executive DirectorDr. Regina M. Benjamin
Non-Executive DirectorProfessor Constantin Coussios
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.